US Broker Ratings

Arbutus Biopharma (ABUS) Stock Analysis: Evaluating a 25% Upside Potential in the Biotechnology Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at the forefront of the biotechnology sector with its focus on developing innovative therapeutics for infectious diseases. Headquartered in Warminster, Pennsylvania, this clinical-stage biopharmaceutical..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring Growth Potential and Analyst Consensus with a Promising 17.76% Upside

AxoGen, Inc. (AXGN) stands as a compelling player in the healthcare sector, specifically within the medical devices industry. As a company dedicated to the development and commercialization of technologies for..

Nuvation Bio Inc. (NUVB) Stock Analysis: Explosive 162% Upside Potential Amid Robust Revenue Growth

Nuvation Bio Inc. (NASDAQ: NUVB), a burgeoning entity in the biotechnology sector, has captured investor attention with its remarkable 162% potential upside, offering a compelling narrative for those seeking high-reward..

Claritev Corporation (CTEV) Stock Analysis: Exploring a 144.85% Potential Upside in Health Information Services

Claritev Corporation (NASDAQ: CTEV) offers an intriguing prospect for investors with a potential upside of 144.85% based on its average target price of $42.75. This healthcare-focused company, renowned for its..

Immatics N.V. (IMTX) Stock Analysis: Exploring an 81% Upside in Cancer Immunotherapy

Immatics N.V. (NASDAQ: IMTX), a German biotechnology firm, is making waves in the healthcare sector with its innovative approach to cancer treatment. Specializing in T cell redirecting immunotherapies, Immatics is..

Akso Health Group (AHG) Stock Analysis: Navigating Through Challenges in the Healthcare Sector

Akso Health Group (NASDAQ: AHG), a prominent player in the healthcare sector in China, has been drawing attention with its distinctive approach to medical distribution and e-commerce. Despite its innovative..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a Potential 136% Upside for Investors

Definitive Healthcare Corp. (NASDAQ: DH) operates within the dynamic Health Information Services industry, providing a comprehensive software-as-a-service (SaaS) healthcare commercial intelligence platform. With a market cap of $112.83 million, the..

Tilray Brands, Inc. (TLRY): Investor Outlook on a Cannabis Leader with 70% Upside Potential

Tilray Brands, Inc. (NASDAQ: TLRY) has become a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Leamington, Canada, Tilray operates on..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech with Nearly 99% Potential Upside

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector. Specializing in the development of therapies for central nervous system (CNS) disorders, Praxis..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: 67.86% Upside Potential and Biotech Innovations

Capricor Therapeutics, Inc. (NASDAQ: CAPR) stands out in the biotechnology sector, offering promising avenues for investors seeking growth opportunities in groundbreaking medical treatments. Based in San Diego, California, Capricor is..

Embecta Corp. (EMBC) Stock Analysis: Is an 88% Upside in Sight for This Healthcare Innovator?

Embecta Corp. (NASDAQ: EMBC), a pivotal player in the healthcare sector, is capturing attention with a potential upside of 88.32%, making it a compelling option for investors seeking value in..

Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook Amidst a Potential 25.60% Upside

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, has captured investor attention with a potential upside of 25.60%, despite facing significant challenges in recent financial..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a 44.67% Potential Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT) stands out in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $525.3 million, the company is positioned as..

Cross Country Healthcare, Inc. (CCRN) Investor Outlook: Navigating a Challenging Market with 27% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a leading player in the healthcare staffing industry, is currently at a pivotal juncture that investors are keenly observing. With a market capitalization of..

Cronos Group Inc. (CRON) Stock Analysis: Is There Potential Despite a 10.65% Downside?

Cronos Group Inc. (CRON), a prominent player in the cannabinoid sector, engages in the cultivation, production, distribution, and marketing of cannabis products across several markets, including Canada and Israel. With..

Tyra Biosciences (TYRA) Stock Analysis: Impressive 28.93% Upside Potential Captures Investor Attention

Tyra Biosciences, Inc. (NASDAQ: TYRA) is making significant waves in the biotechnology sector, with a market capitalization of $2.13 billion as it spearheads the development of precision medicines targeting fibroblast..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a Potential 181.34% Upside in Telehealth

LifeMD, Inc. (NASDAQ: LFMD) is navigating the healthcare landscape with a distinct focus on telehealth services. Despite facing some financial hurdles, the company’s potential for significant upside has caught the..

Arvinas, Inc. (ARVN) Stock Analysis: Unlocking a 37% Potential Upside in Biotech Innovations

Investors with a keen eye for opportunities in the biotechnology sector might find Arvinas, Inc. (NASDAQ: ARVN), a compelling stock to watch. Specializing in the discovery and development of therapies..

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring a 65% Potential Upside in the Biotechnology Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is carving a niche in the healthcare sector, specifically in biotechnology, where it focuses on developing treatments for various cancers. Based in Newtown Square, Pennsylvania,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds